Helicobacter pylori 1,3-N-acetylglucosaminyltransferase for versatile synthesis of type 1 and type 2 poly-LacNAcs on N-linked, O-linked and I-antigen glycans

Glycobiology

Volumn 22, Issue 11, 2012, Pages 1453-1464

  Peng, Wenjie ^a,b   Pranskevich, Jennifer ^a,b   Nycholat, Corwin ^b   Gilbert, Michel ^c   Wakarchuk, Warren ^c   Paulson, James C ^a,b   Razi, Nahid ^a,b  

^a Consortium for Functional Glycomics ^*  (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

3 N acetylglucosaminyltransferase; acceptor specificity; chemo enzymatic synthesis; glycopeptides and glycolipids; polylactosaminoglycan

Indexed keywords

BETA 3 N ACETYLGLUCOSAMINYLTRANSFERASE; GLYCAN DERIVATIVE; GLYCOPEPTIDE; N ACETYLGLUCOSAMINE; N ACETYLGLUCOSAMINYLTRANSFERASE; UNCLASSIFIED DRUG; AMINOSUGAR; BLOOD GROUP I ANTIGEN; GLYCOSPHINGOLIPID; I-ANTIGEN; N ACETYLLACTOSAMINE; N-ACETYLLACTOSAMINE; POLYLACTOSAMINE; POLYSACCHARIDE;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; ENZYME ACTIVITY; ENZYME SUBSTRATE COMPLEX; HELICOBACTER PYLORI; PRIORITY JOURNAL; PROTEIN MOTIF; PROTON NUCLEAR MAGNETIC RESONANCE; SYNTHESIS; BIOSYNTHESIS; CHEMISTRY; ENZYMOLOGY; GLYCOSYLATION; METABOLISM;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI;

ACETYLGLUCOSAMINE; AMINO SUGARS; GLYCOSPHINGOLIPIDS; GLYCOSYLATION; HELICOBACTER PYLORI; N-ACETYLGLUCOSAMINYLTRANSFERASES; POLYSACCHARIDES;

EID: 84868027568     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cws101     Document Type: Article

References (53)

1. Bateman AC, Karamanska R, Busch MG, Dell A, Olsen CW, Haslam SM. 2010. Glycan analysis and influenza A virus infection of primary swine respiratory epithelial cells: The importance of NeuAcα2-6 glycans. J Biol Chem. 285:34016-34026.
2. Chandrasekaran A, Srinivasan A, Raman R, Viswanathan K, Raguram S, Tumpey TM, Sasisekharan V, Sasisekharan R. 2008. Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin. Nat Biotechnol. 26:107-113.
3. Cummings RD, Kornfeld S. 1984. The distribution of repeating [Gal beta 1,4GlcNAc beta 1,3] sequences in asparagine-linked oligosaccharides of the mouse lymphoma cell lines BW5147 and PHAR 2.1. J Biol Chem. 259:6253-6260.
4. Dejter-Juszynski M, Harpaz N, Flowers HM, Sharon N. 1978. Blood-group ABH-specific macroglycolipids of human erythrocytes: Isolation in high yield from a crude membrane glycoprotein fraction. Eur J Biochem. 83:363-373.
5. Dennis JW, Lau KS, Demetriou M, Nabi IR. 2009. Adaptive regulation at the cell surface by N-glycosylation. Traffic. 10:1569-1578.
6. Fan YY, Yu SY, Ito H, Kameyama A, Sato T, Lin CH, Yu LC, Narimatsu H, Khoo KH. 2008. Identification of further elongation and branching of dimeric type 1 chain on lactosylceramides from colonic adenocarcinoma by tandem mass spectrometry sequencing analyses. J Biol Chem. 283:16455-16468.
7. Fenderson BA, Eddy EM, Hakomori S. 1990. Glycoconjugate expression during embryogenesis and its biological significance. Bioessays. 12:173-179.
8. Fukuda M. 1980. K562 human leukaemic cells express fetal type (i) antigen on different glycoproteins from circulating erythrocytes. Nature. 285: 405-407.
9. Fukuda M, Carlsson SR, Klock JC, Dell A. 1986. Structures of O-linked oligosaccharides isolated from normal granulocytes, chronic myelogenous leukemia cells, and acute myelogenous leukemia cells. J Biol Chem. 261: 12796-12806.
10. Fukuda M, Dell A, Oates JE, Fukuda MN. 1984. Structure of branched lactosaminoglycan, the carbohydrate moiety of band 3 isolated from adult human erythrocytes. J Biol Chem. 259:8260-8273.
11. Fukuda M, Fukuda MN, Hakomori S. 1979. Developmental change and genetic defect in the carbohydrate structure of band 3 glycoprotein of human erythrocyte membrane. J Biol Chem. 254:3700-3703.
12. Fukuda M, Fukuda MN, Papayannopoulou T, Hakomori S. 1980. Membrane differentiation in human erythroid cells: Unique profiles of cell surface glycoproteins expressed in erythroblasts in vitro from three ontogenic stages. Proc Natl Acad Sci USA. 77:3474-3478.
13. Fukuda MN, Hakomori S. 1982. Structures of branched blood group A-active glycosphingolipids in human erythrocytes and polymorphism of A-and H-glycolipids in A1 and A2 subgroups. J Biol Chem. 257:446-455.
14. Greiling H. 1994. Structure and biological functions of keratan sulfate proteoglycans. Exs. 70:101-122.
15. Holmes EH. 1989. Characterization and membrane organization of beta 1,3-and beta 1,4-galactosyltransferases from human colonic adenocarcinoma cell lines Colo 205 and SW403: Basis for preferential synthesis of type 1 chain lacto-series carbohydrate structures. Arch Biochem Biophys. 270: 630-646.
16. Horlacher T, Oberli MA, Werz DB, Krock L, Bufali S, Mishra R, Sobek J, Simons K, Hirashima M, Niki T, et al. 2010. Determination of carbohydrate-binding preferences of human galectins with carbohydrate microarrays. ChemBioChem. 11:1563-1573.
17. Jarnefelt J, Rush J, Li YT, Laine RA. 1978. Erythroglycan, a high molecular weight glycopeptide with the repeating structure [galactosyl-(1 leads to 4)-2-deoxy-2-acetamido-glucosyl(1 leads to 3)] comprising more than one-third of the protein-bound carbohydrate of human erythrocyte stroma. J Biol Chem. 253:8006-8009.
18. Korekane H, Taguchi T, Sakamoto Y, Honke K, Dohmae N, Salminen H, Toivonen S, Helin J, Takio K, Renkonen O, et al. 2003. Purification and cDNA cloning of UDP-GlcNAc:GlcNAcbeta1-3Galbeta1-4Glc(NAc)-R [GlcNAc to Gal]beta1,6N-acetylglucosaminyltransferase from rat small intestine: A major carrier of dIGnT activity in rat small intestine. Glycobiology. 13:387-400.
19. Leppanen A, Niemela R, Renkonen O. 1997. Enzymatic midchain branching of polylactosamine backbones is restricted in a site-specific manner in α1,3-fucosylated chains. Biochemistry. 36:13729-13735.
20. Leppanen A, Penttila L, Renkonen O, McEver RP, Cummings RD. 2002. Glycosulfopeptides with O-glycans containing sialylated and polyfucosylated polylactosamine bind with low affinity to P-selectin. J Biol Chem. 277:39749-39759.
21. Leppanen A, Salminen H, Zhu Y, Maaheimo H, Helin J, Costello CE, Renkonen O. 1997. In vitro biosynthesis of a decasaccharide prototype of multiply branched polylactosaminoglycan backbones. Biochemistry. 36:7026-7036.
22. Lin CH, Fan YY, Chen YY, Wang SH, Chen CI, Yu LC, Khoo KH. 2009. Enhanced expression of beta 3-galactosyltransferase 5 activity is sufficient to induce in vivo synthesis of extended type 1 chains on lactosylceramides of selected human colonic carcinoma cell lines. Glycobiology. 19:418-427.
23. Logan SM, Altman E, Mykytczuk O, Brisson JR, Chandan V, Schur MJ, St Michael F, Masson A, Leclerc S, Hiratsuka K et al. 2005. Novel biosynthetic functions of lipopolysaccharide rfaJ homologs from Helicobacter pylori. Glycobiology. 15:721-733.
24. Maaheimo H, Penttila L, Renkonen O. 1994. Enzyme-aided construction of medium-sized alditols of complete O-linked saccharides. The constructed hexasaccharide alditol Gal beta 1-4GlcNAc beta 1-6Gal beta 1-4GlcNAc beta 1-6(Gal beta 1-3)GalNAc-ol resists the action of endo-betagalactosidase from Bacteroides fragilis. FEBS Lett. 349:55-59.
25. Maaheimo H, Renkonen R, Turunen JP, Penttila L, Renkonen O. 1995. Synthesis of a divalent sialyl Lewis x O-glycan, a potent inhibitor of lymphocyte-endothelium adhesion. Evidence that multivalency enhances the saccharide binding to L-selectin. Eur J Biochem. 234:616-625.
26. McAuliffe JC, Fukuda M, Hindsgaul O. 1999. Expedient synthesis of a series of N-acetyllactosamines. Bioorg Med Chem Lett. 9:2855-2858.
27. Mitoma J, Petryniak B, Hiraoka N, Yeh JC, Lowe JB, Fukuda M. 2003. Extended core 1 and core 2 branched O-glycans differentially modulate sialyl Lewis X-type L-selectin ligand activity. J Biol Chem. 278:9953-9961.
28. Muramatsu H, Kusano T, Sato M, Oda Y, Kobori K, Muramatsu T. 2008. Embryonic stem cells deficient in I β1,6-N-acetylglucosaminyltransferase exhibit reduced expression of embryoglycan and the loss of a Lewis X antigen, 4C9. Glycobiology. 18:242-249.
29. Muramatsu T, Muramatsu H. 2004. Carbohydrate antigens expressed on stem cells and early embryonic cells. Glycoconj J. 21:41-45.
30. Nagae M, Nishi N, Murata T, Usui T, Nakamura T, Wakatsuki S, Kato R. 2009. Structural analysis of the recognition mechanism of poly-N- acetyllactosamine by the human galectin-9 N-terminal carbohydrate recognition domain. Glycobiology. 19:112-117.
31. Naruchi K, Hamamoto T, Kurogochi M, Hinou H, Shimizu H, Matsushita T, Fujitani N, Kondo H, Nishimura S. 2006. Construction and structural characterization of versatile lactosaminoglycan-related compound library for the synthesis of complex glycopeptides and glycosphingolipids. J Org Chem. 71:9609-9621.
32. Nieduszynski IA, Huckerby TN, Dickenson JM, Brown GM, Tai GH, Bayliss MT. 1990. Structural aspects of skeletal keratan sulphates. Biochem Soc Trans. 18:792-793.
33. Niemela R, Natunen J, Majuri ML, Maaheimo H, Helin J, Lowe JB, Renkonen O, Renkonen R. 1998. Complementary acceptor and site specificities of Fuc-TIV and Fuc-TVII allow effective biosynthesis of sialyl-TriLex and related polylactosamines present on glycoprotein counterreceptors of selectins. J Biol Chem. 273:4021-4026.
34. Nycholat CM, McBride R, Ekiert DC, Xu R, Rangarajan J, Peng W, Razi N, Gilbert M, Wakarchuk W, Wilson IA, et al. 2012. Recognition of sialylated poly-N-acetyllactosamine chains on N-and O-linked glycans by human and avian influenza A virus hemagglutinins. Angew Chem Int Ed Engl. 51:4860-4863.
35. Renkonen O. 2000. Enzymatic in vitro synthesis of I-branches of mammalian polylactosamines: Generation of scaffolds for multiple selectin-binding saccharide determinants. Cell Mol Life Sci. 57:1423-1439.
36. Renkonen O, Toppila S, Penttila L, Salminen H, Helin J, Maaheimo H, Costello CE, Turunen JP, Renkonen R. 1997. Synthesis of a new nanomolar saccharide inhibitor of lymphocyte adhesion: Different polylactosamine backbones present multiple sialyl Lewis x determinants to L-selectin in high-affinity mode. Glycobiology. 7:453-461.
37. Sauerzapfe B, Krenek K, Schmiedel J, Wakarchuk WW, Pelantova H, Kren V, Elling L. 2009. Chemo-enzymatic synthesis of poly-N-acetyllactosamine (poly-LacNAc) structures and their characterization for CGL2-galectin-mediated binding of ECM glycoproteins to biomaterial surfaces. Glycoconj J. 26:141-159.
38. Seppo A, Penttila L, Niemela R, Maaheimo H, Renkonen O, Keane A. 1995. Enzymatic synthesis of octadecameric saccharides of multiply branched blood group I-type, carrying four distal α1,3-galactose or β1,3-GlcNAc residues. Biochemistry. 34:4655-4661.
39. Severov VV, Belyanchikov IM, Pazynina GV, Bovin NV. 2007. Synthesis of N-acetyllactosamine-containing oligosaccharides, galectin ligands. Russ J Bioorg Chem+. 33:122-138.
40. Srinivasan N, Bane SM, Ahire SD, Ingle AD, Kalraiya RD. 2009. Poly N-acetyllactosamine substitutions on N-and not O-oligosaccharides or Thomsen-Friedenreich antigen facilitate lung specific metastasis of melanoma cells via galectin-3. Glycoconj J. 26:445-456.
41. Stowell SR, Arthur CM, Slanina KA, Horton JR, Smith DF, Cummings RD. 2008. Dimeric Galectin-8 induces phosphatidylserine exposure in leukocytes through polylactosamine recognition by the C-terminal domain. J Biol Chem. 283:20547-20559.
42. Togayachi A, Kozono Y, Ishida H, Abe S, Suzuki N, Tsunoda Y, Hagiwara K, Kuno A, Ohkura T, Sato N, et al. 2007. Polylactosamine on glycoproteins influences basal levels of lymphocyte and macrophage activation. Proc Natl Acad Sci USA. 104:15829-15834.
43. Togayachi A, Kozono Y, Kuno A, Ohkura T, Sato T, Hirabayashi J, Ikehara Y, Narimatsu H. 2010. Beta3GnT2 (B3GNT2), a major polylactosamine synthase: Analysis of B3GNT2-deficient mice. Methods Enzymol. 479:185-204.
44. Turco SJ, Rush JS, Laine RA. 1980. Presence of erythroglycan on human K-562 chronic myelogenous leukemia-derived cells. J Biol Chem. 255: 3266-3269.
45. Ujita M, McAuliffe J, Hindsgaul O, Sasaki K, Fukuda MN, Fukuda M. 1999. Poly-N-acetyllactosamine synthesis in branched N-glycans is controlled by complemental branch specificity of i-extension enzyme and beta 1,4-galactosyltransferase I. J Biol Chem. 274:16717-16726.
46. Ujita M, McAuliffe J, Suzuki M, Hindsgaul O, Clausen H, Fukuda MN, Fukuda M. 1999. Regulation of I-branched poly-N-acetyllactosamine synthesis. Concerted actions by I-extension enzyme, I-branching enzyme, and beta1,4- galactosyltransferase I. J Biol Chem. 274:9296-9304.
47. Ujita M, M J, Hindsgaul O, Sasaki K, Fukuda MN, Fukuda M. 1999. Poly-N-acetyllactosamine synthesis in branched N-glycans is controlled by complemental branch specificity of i-extension enzyme and β1,4- galactosyltransferase I. J Biol Chem. 274:16717-16726.
48. Ujita M, Misra AK, McAuliffe J, Hindsgaul O, Fukuda M. 2000. Poly-N-acetyllactosamine extension in N-glycans and core 2-and core 4-branched O-glycans is differentially controlled by i-extension enzyme and different members of the beta 1,4-galactosyltransferase gene family. J Biol Chem. 275:15868-15875.
49. Vasiliu D, Razi N, Zhang Y, Jacobsen N, Allin K, Liu X, Hoffmann J, Bohorov O, Blixt O. 2006. Large-scale chemoenzymatic synthesis of blood group and tumor-associated poly-N-acetyllactosamine antigens. Carbohydr Res. 341:1447-1457.
50. Wilkins PP, McEver RP, Cummings RD. 1996. Structures of the O-glycans on P-selectin glycoprotein ligand-1 from HL-60 cells. J Biol Chem. 271:18732-18742.
51. Yeh JC, Hiraoka N, Petryniak B, Nakayama J, Ellies LG, Rabuka D, Hindsgaul O, Marth JD, Lowe JB, Fukuda M. 2001. Novel sulfated lymphocyte homing receptors and their control by a core1 extension beta 1,3-N- acetylglucosaminyltransferase. Cell. 105:957-969.
52. Yousefi S, Higgins E, Daoling Z, Pollex-Kruger A, Hindsgaul O, Dennis JW. 1991. Increased UDP-GlcNAc:Gal beta 1-3GaLNAc-R (GlcNAc to GaLNAc) beta-1, 6-N-acetylglucosaminyltransferase activity in metastatic murine tumor cell lines. Control of polylactosamine synthesis. J Biol Chem. 266:1772-1782.
53. Zdebska E, Krauze R, Koscielak J. 1983. Structure and blood-group I activity of poly(glycosyl)-ceramides. Carbohydr Res. 120:113-130.